Guizhou Sanli Pharmaceutical Co., Ltd. is a leading medical devices company based in Guizhou Province, Anshun City, Pingba District, Xiayun Industrial Park, Anshun City, Guizhou Province, China. Established in 1995, the company operates within the Health Care, Manufacturing, and Pharmaceutical industries, contributing to the advancement of healthcare and therapeutic innovations.
Renowned for its commitment to "Creating a healthy life for humanity," Guizhou Sanli Pharmaceutical has attracted attention from Timesbole, which made a Post-IPO Equity investment in the company on 05 July 2022. This strategic investment marks an important milestone in the company's growth and underscores its potential in the global healthcare market.